Guiyang Xintian Pharmaceutical Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was CNY 454.031 million compared to CNY 302.862 million a year ago. Operating income was CNY 56.241 million compared to CNY 31.682 million a year ago. Net income was CNY 46.837 million compared to CNY 25.204 million a year ago. Basic earnings per share from continuing operations was CNY 0.41 compared to CNY 0.2193 a year ago. Diluted earnings per share from continuing operations was CNY 0.3811 compared to CNY 0.2067 a year ago.